Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Mol Biotechnol ; 61(6): 400-409, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30945164

RESUMEN

Transgenic chickens are of great interest for the production of recombinant proteins in their eggs. However, the use of constitutive strong promoters or the tissue-specific ovalbumin promoter for the generation of the transgenic chickens have different drawbacks that have to be overcome in order to make chicken bioreactor an efficient production system. This prompted us to investigate the use of an alternative tissue-specific promoter, the vitellogenin promoter, which could overcome the difficulties currently found in the generation of chicken bioreactors. In the present work we establish and characterize a DNA construct consisting of a fragment of the 5´-flanking region of the chicken vitellogenin II gene cloned in a reporter vector. This construct is capable of showing the ability of the promoter to drive expression of a reporting gene in a tissue-specific manner and in a way that closely resembles physiologic regulation of vitellogenin, making it an ideal candidate to be used in the future for generation of avian bioreactors. Besides, we validate an in vitro culture system to test the performance of the DNA construct under study that could be used as a practical tool before generating any transgenic chicken. These results are important since they provide the proof of concept for the use of the vitellogenin promoter for future genetic modification of chickens bioreactors with improved characteristics in terms of quality of the recombinant protein produced.


Asunto(s)
Proteínas Aviares/genética , Pollos/genética , Vectores Genéticos/química , Proteínas Recombinantes de Fusión/genética , Vitelogeninas/genética , Región de Flanqueo 5' , Animales , Animales Modificados Genéticamente , Proteínas Aviares/metabolismo , Reactores Biológicos , Embrión de Pollo , Pollos/metabolismo , Clonación Molecular , Estradiol/farmacología , Femenino , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Regulación de la Expresión Génica , Genes Reporteros , Vectores Genéticos/metabolismo , Hepatocitos/citología , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Luciferasas/genética , Luciferasas/metabolismo , Cultivo Primario de Células , Regiones Promotoras Genéticas , Receptores de Estrógenos , Proteínas Recombinantes de Fusión/metabolismo , Transfección/métodos , Vitelogeninas/metabolismo , Cigoto/efectos de los fármacos , Cigoto/crecimiento & desarrollo , Cigoto/metabolismo
2.
Cell Reprogram ; 18(3): 154-61, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27253627

RESUMEN

Primordial germ cells (PGCs) are the undifferentiated progenitors of gametes. Germline competent PGCs can be developed as a cell-based system for genetic modification in chickens, which provides a valuable tool for transgenic technology with both research and industrial applications. This implies manipulation of PGCs, which, in recent years, encouraged a lot of research focused on the study of PGCs and the way of improving their culture. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that besides mediating toxic responses to environmental contaminants plays pivotal physiological roles in various biological processes. Since a novel compound that acts as an antagonist of this receptor has been reported to promote expansion of hematopoietic stem cells, we conducted the present study with the aim of determining whether addition of an established AHR antagonist to the standard culture medium used nowadays for in vitro chicken PGCs culture improves ex vivo expansion. We have found that addition of α-naphthoflavone in culture medium promotes the amplification of undifferentiated cells and that this effect is exerted by the blockade of AHR action. Our results constitute the first report of the successful use of a readily available AHR antagonist to improve avian PGCs expansion, and they further extend the knowledge of the effects of AHR modulation in undifferentiated cells.


Asunto(s)
Benzoflavonas/farmacología , Células Germinativas/citología , Células Germinativas/efectos de los fármacos , Receptores de Hidrocarburo de Aril/antagonistas & inhibidores , Transducción de Señal , Animales , Células Cultivadas , Pollos , Femenino
3.
Mol Cell Endocrinol ; 221(1-2): 9-19, 2004 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-15223128

RESUMEN

Mammary gland morphogenesis and differentiation are mediated through the combined activities of systemic hormones and locally synthesized growth factors. Activin, a member of the transforming growth factor (TGF)-beta superfamily, is known to regulate the growth and differentiation of several cell types. In the present study, we investigated the role of activin in rat mammary gland on different stages of development. We found that activin A in vitro inhibits the proliferation of isolated acini, and this effect increases with the development of the gland. This factor also produces in vitro an inhibition of the final differentiation of acini obtained from 19th day pregnant rats. We also report the expression of activin receptors IIA and IIB mRNA in whole rat mammary gland and acini, with decreased levels of expression of type IIA (in both compartments) and IIB (in acini) during pregnancy and lactogenesis. In addition, we show that activin betaB-subunit mRNA decreases throughout pregnancy, and that the mRNA levels of follistatin (Fst) (its ligand protein) are high in cycling rats and at the beginning of pregnancy and diminish thereafter, having the acini higher levels of expression. Our data show that activin betaB-subunit, follistatin and ActRIIA and IIB transcripts are expressed in rat mammary gland at appropriate times and locations during development, allowing an interplay that might regulate activin action on growth and differentiation of the gland.


Asunto(s)
Activinas/fisiología , Folistatina/biosíntesis , Subunidades beta de Inhibinas/fisiología , Glándulas Mamarias Animales/crecimiento & desarrollo , Receptores de Activinas/biosíntesis , Receptores de Activinas/genética , Activinas/genética , Activinas/farmacología , Animales , Caseínas/biosíntesis , Caseínas/genética , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Femenino , Folistatina/genética , Folistatina/farmacología , Regulación de la Expresión Génica , Subunidades beta de Inhibinas/biosíntesis , Subunidades beta de Inhibinas/genética , Subunidades beta de Inhibinas/farmacología , Inhibinas/biosíntesis , Inhibinas/genética , Lactancia/fisiología , Glándulas Mamarias Animales/efectos de los fármacos , Glándulas Mamarias Animales/fisiología , Embarazo , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Factor de Crecimiento Transformador beta/farmacología
4.
Artículo en Inglés | MEDLINE | ID: mdl-23103859

RESUMEN

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates most of the toxic effects of environmental contaminants. Among the multiple pleiotropic responses elicited by AHR agonists, the antiestrogenic and endocrine-disrupting action of the receptor activation is one of the most studied. It has been demonstrated that some AHR agonists disrupt estradiol-induced vitellogenin synthesis in the fish liver via a mechanism that involves crosstalk between the AHR and the estrogen receptor (ER). Chicken hepatocytes have become a model for the study of AHR action in birds and the induction of the signal and its effect in these cells are well established. However, the impact of AHR activation on estradiol-regulated responses in the chicken liver remains to be demonstrated. The aim of the present study was, therefore, to determine the effect of AHR action on ER-driven transcription in a convenient model of chicken liver cells. For this purpose, we designed a reporter construct bearing the 5' regulatory region of the chicken vitellogenin II gene and used it to transfect chicken hepatoma LMH cells. We found that ß-naphthoflavone represses ER-driven vitellogenin promoter activity and that this action is mediated by the AHR. This inhibitory crosstalk between both pathways appears to be unidirectional, since estradiol did not alter the transcript levels of an AHR target gene. Besides, and highly relevant, we show that LMH cell line transfected with a reporter construct bearing the chicken vitellogenin promoter sequence is a useful and convenient model for the study of AHR-ER interaction in chicken liver-derived cells.


Asunto(s)
Estradiol/farmacología , Expresión Génica/efectos de los fármacos , Regiones Promotoras Genéticas/genética , Receptores de Hidrocarburo de Aril/metabolismo , Vitelogeninas/genética , Animales , Hidrocarburo de Aril Hidroxilasas/genética , Proteínas Aviares/genética , Línea Celular Tumoral , Células Cultivadas , Embrión de Pollo , Pollos , Inhibidores Enzimáticos/farmacología , Estrógenos/farmacología , Técnica del Anticuerpo Fluorescente , Microscopía Confocal , Unión Proteica , Receptores de Hidrocarburo de Aril/agonistas , Receptores de Estrógenos/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , beta-naftoflavona/farmacología
5.
Biol Reprod ; 74(2): 417-26, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16237154

RESUMEN

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that, besides mediating toxic responses, may have a central role in ovarian physiology. Studying the actions of AHR ligands on granulosa cells function, we have found that beta-naphthoflavone amplifies the comitogenic actions of FSH and 17beta-estradiol in a dose-dependent manner. This amplification was even greater in cells that overexpress the AHR and was reversed by cotreatment with the AHR antagonist alpha-naphthoflavone, suggesting that this effect is mediated by the AHR. The estrogen receptor is likewise implicated in this phenomenon, because a pure antiestrogen abolished the described synergism. However, the more traditional inhibitory AHR-estrogen receptor interaction was observed on the estrogen response element-driven transcriptional activity. On the other hand, alpha-naphthoflavone inhibited dose-dependently the mitogenic actions of FSH and 17beta-estradiol. Beta-naphthoflavone induced the expression of Cyp1a1 and Cyp1b1 transcripts, two well-characterized AHR-inducible genes that code for hydroxylases that metabolize estradiol to catecholestrogens. Nevertheless, the positive effect of beta-naphthoflavone on proliferation was not caused by increased metabolism of estradiol to catecholestrogens, because these compounds inhibited the hormonally stimulated DNA synthesis. This latter inhibition exerted by catecholestrogens suggests that these hydroxylases would play a regulatory point in granulosa cell proliferation. Our study indicates that AHR ligands modulate the proliferation of rat granulosa cells, and demonstrates for the first time that an agonist of this receptor is able to amplify the comitogenic action of classical hormones through a mechanism that might implicate a positive cross-talk between the AHR and the estrogen receptor pathways.


Asunto(s)
Estradiol/farmacología , Células de la Granulosa/efectos de los fármacos , Receptores de Hidrocarburo de Aril/agonistas , beta-naftoflavona/farmacología , Animales , Hidrocarburo de Aril Hidroxilasas/efectos de los fármacos , Hidrocarburo de Aril Hidroxilasas/genética , Benzoflavonas/farmacología , Células Cultivadas , Citocromo P-450 CYP1A1/efectos de los fármacos , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1B1 , ADN/biosíntesis , ADN/efectos de los fármacos , Sinergismo Farmacológico , Estrógenos de Catecol/farmacología , Femenino , Hormona Folículo Estimulante/farmacología , Células de la Granulosa/metabolismo , Mitógenos/farmacología , ARN Mensajero/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Receptores de Hidrocarburo de Aril/antagonistas & inhibidores , Receptores de Hidrocarburo de Aril/metabolismo , Receptores de Estrógenos/efectos de los fármacos , Receptores de Estrógenos/metabolismo , Activación Transcripcional/efectos de los fármacos
6.
J Comp Physiol B ; 176(3): 243-51, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16292562

RESUMEN

Environmental pollution with endocrine disrupting compounds (EDCs) has adverse effects on the ecosystem's health. Caiman latirostris are widely distributed in South American aquatic ecosystems. Caimans have physiological and ecological characteristics that make them particularly vulnerable to EDCs exposure and suitable candidate as a sentinel species. Vitellogenin (Vtg) is a yolk pre-cursor protein synthesized by the liver of non-mammalian vertebrates and induced in response to estrogen. Purified plasma Vtg from caimans injected with estradiol-17beta (E2) was used to generate a polyclonal anti-body. Anti-body specificity was assessed using Western blot. The antiserum was also effective in detecting turtle Vtg, exhibiting high cross-reactivity with Vtg from Phrynops hilarii and Trachemys scripta dorbigni. We developed a specific and highly sensitive ELISA for caiman Vtg. This method has a detection limit of 0.1 ng/ml of plasma. The ELISA did not detect Vtg in plasma of non-induced male caimans. Induction of Vtg in male caimans was evaluated in response to one or two (7 days apart) doses of E2. Due to its high sensitivity, ELISA allows to measure the small increases in plasma Vtg after exposure to exogenous estrogen. A priming effect was observed following the second E2 dose, with a tenfold increase in circulating Vtg. Hepatic synthesis was confirmed by immunohistochemistry. The results presented herein suggest that detection of plasma Vtg in male caimans might become a valuable tool in biomonitoring xenoestrogen exposure in a polluted environment.


Asunto(s)
Caimanes y Cocodrilos/metabolismo , Ecosistema , Exposición a Riesgos Ambientales/análisis , Estrógenos/farmacología , Vitelogeninas/análisis , Contaminantes Químicos del Agua/farmacología , Animales , Western Blotting , Ensayo de Inmunoadsorción Enzimática , Estrógenos/química , Femenino , Immunoblotting , Masculino , Sensibilidad y Especificidad , Tortugas/metabolismo , Vitelogeninas/metabolismo , Contaminantes Químicos del Agua/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA